Accepted for/Published in: JMIR Research Protocols
Date Submitted: May 19, 2025
Open Peer Review Period: May 20, 2025 - Jul 15, 2025
Date Accepted: Dec 10, 2025
(closed for review but you can still tweet)
Clinical Evidence Profile of Oral Chinese Patent Ethnomedicines: A Scoping Review and Evidence Map Protocol
ABSTRACT
Background:
Chinese patent ethnomedicines(CPMs) are a form of traditional Chinese patent medicine that originate from the traditional medicines of ethnic minorities and are widely used in clinical practice. However, existing evidence for their application remains unclear. Therefore, to address this gap, this comprehensive scoping review will be performed to provide an overview of the available evidence from Chinese patent ethnomedicine preparations.
Objective:
This review aims to provide the evidence profile of oral CPMs. This study will elucidate the current state of the evidence with respect to these medicines and identify research gaps. The detailed steps for conducting this review are outlined in this protocol. This review will contribute to a better understanding of CPMs.
Methods:
This review will include clinical studies of CPMs irrespective of study design. The frameworks described by Arksey and O'Malley, Levac, and the Joanna Briggs Institute will be used to guide the current scoping review. This review will include six steps: (1) identify the research question;(2) collect information about Chinese patent ethnomedicines from national related drug catalogues; (3) search the MEDLINE (via PubMed), Embase, Web of Science, Cochrane Library and Chinese databases from inception to February 2025 to identify relevant publications; (4) screen the literature against the eligibility criteria; (5) extract data by using a predefined standardized data extraction form; and (6) summarize, discuss, analyse, and report the results. We will also present the results via data visualization techniques.
Results:
We will synthesize data on CPMs by conducting the Scoping Review, drawing the evidence maps, identifying the clinical research characteristics related to AEs features identifying , as well as highlighting the limitations and gaps in the literature. We expect to publish the results in 2026.
Conclusions:
The information obtained through this review could inform future research involving CPMs. Clinical Trial: Review registration number https://osf.io/e763b.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.